Investors in hospital companies have cooled their heels in recent weeks after seeing Q2 earnings reports and realizing that weak volume trends look likely to persist. Lewis Krauskopf at Reuters writes that another limiting factor is that emerging consensus that the implementation of health care reform won't bring with it a big and instant bottom-line boost. And things are likely to get bumpy this fall as headlines emerge about the enrollment trends for insurance exchanges.